ANI Pharmaceuticals, Inc. (ANIP) vs Intellia Therapeutics, Inc. (NTLA)
A side-by-side comparison of ANI Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIP
ANI Pharmaceuticals, Inc.
$71.53HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
NTLA
Intellia Therapeutics, Inc.
$12.48HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT
Total return — ANIP vs NTLA
growth of $100 · dividends reinvested · last 10yANIP +5.2% (+0.5%/yr)NTLA -26.5% (-3.0%/yr)ANIP compounded faster over this window
ANIP NTLA
ANIP vs NTLA: by the numbers
- •NTLA is the larger company ($1.74B vs $1.63B market cap).
- •ANIP is profitable (10.82% net margin) while NTLA runs a net loss (-672.16%).
- •ANIP grew revenue faster over the past five years (35.61% vs 7.31% CAGR).
Metrics side by side
Valuation
| Metric | ANIP | NTLA |
|---|---|---|
| P/E ratio | 15.45 | N/A |
| Forward P/E | 7.71 | N/A |
| P/S ratio | 1.66 | 29.30 |
| P/B ratio | 2.72 | 2.40 |
| EV / EBITDA | 6.76 | N/A |
Profitability
| Metric | ANIP | NTLA |
|---|---|---|
| Gross margin | 51.01% | 76.47% |
| Operating margin | 15.35% | -651.67% |
| Net margin | 10.82% | -672.16% |
| ROE | 17.72% | -54.96% |
| ROIC | 9.26% | -54.45% |
Growth (annualized)
| Metric | ANIP | NTLA |
|---|---|---|
| Revenue CAGR (5Y) | 35.61% | 7.31% |
| Total return CAGR (5Y) | 16.86% | -37.13% |
Frequently asked
- Which has grown faster, ANIP or NTLA?
- Over the past five years, ANIP grew revenue faster — ANIP at a 35.61% CAGR versus NTLA at 7.31%.
- Is ANIP or NTLA more profitable?
- ANIP runs the higher net margin — ANIP at 10.82% versus NTLA at -672.16%.
- How have ANIP and NTLA total returns compared?
- Over the past 10 years, ANIP delivered 0.51% and NTLA delivered -3.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ANI Pharmaceuticals P/E ratioANI Pharmaceuticals ROEIntellia Therapeutics ROEANI Pharmaceuticals operating marginIntellia Therapeutics operating marginANI Pharmaceuticals revenue growthIntellia Therapeutics revenue growthANI Pharmaceuticals free cash flowIntellia Therapeutics free cash flow
ANI Pharmaceuticals & Intellia Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.